Karo Bio To Acquire Novalon

is acquiring the American biotechnology company based in Durham, North Carolina through a non- cash issue.

“The acquisition of Novalon will strengthen Karo Bio’s technology base for the development of new drug substances that act upon nuclear receptors, which will make it possible to start several new projects and partnerships.

It also provides Karo Bio with an opportunity to develop research programs in new areas such as the identification of therapeutics that act upon new pharmaceutical targets derived from discoveries coming from genomics research.

With operations in Europe and the United States, Karo Bio will have better exposure to future collaborative partners and institutional investors,” says Mr. Per- Olof Martensson, President and CEO of Karo Bio.

“By joining with Karo Bio, Novalon is gaining an opportunity to fully exploit the technology platform the company has developed.

The merging of our technologies and research programs will greatly accelerate the pace and scope of our joint drug development,” says Dr. Dana Fowlkes, Chairman, CEO and founder of Novalon.

The new Karo Bio will have collaborative agreements with the leading life science companies , , Inc., Bayer AG, Ares-, . and Research Foundation.

The joint technology platforms encompass both nuclear receptors and genomics.

The deal is conditional on Karo Bio‘s shareholders approving a directed new share issue at the Annual General Meeting on 26 April.

In addition, at that meeting and as a first step towards a stock exchange listing abroad, the company shall propose a new share issue with a value of around SEK 200 million directed to institutional investors.

Karo Bio is a research-based pharmaceutical company developing tissue-selective drug substances that act via nuclear receptors for the treatment of common diseases such as diabetes, obesity, elevated cholesterol, inflammatory disorders, cancer, cardiovascular diseases and certain women’s health problems.

Development takes place in collaboration with international pharmaceutical companies and leading universities.

Purchasing Dragon Pharma on the Internet

Primobolan 100 - Cheap Price

Administration: Injection
Basic Ingredient: Methenolone Enanthate
Producer: Dragon Pharma LLC
Package: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $65.00

Cut Mix 150 - Cheap Price

Administration: Injection
Primary Chemical Name: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Manufacturer: Dragon Pharmaceuticals
Package: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $46.00

Cypionat 250 - Discount Price

Administration: Injection
Primary Substance: Testosterone Cypionate
Manufacturer: Dragon Pharmaceuticals
Amount: 30 x 10 mL vial (250 mg/mL)
Price: 30 x $25.00


Beta-2 Agonist, Bronchodilator
Primary Chemical Name: Clenbuterol Hydrochloride
Made by: Dragon Pharma
Package: 1 X 100 tabs (40 mcg/tablet)

Trenbolone 200 - Discount Price

Administration: Injection
Basal Component: Trenbolone Enanthate
Produced by: Dragon Pharmaceuticals
Pack: 30 x 10 mL vial (200 mg/mL)
Price: 30 x $57.00

Sustanon 350 - Bulk Price

Administration: Injection
Base Substance: Testosterone Blend
Manufacturer: Dragon Pharma
Unit: 10 x 10 mL vial (350 mg/mL)
Price: 10 x $45.00

Primobolan 200

Injectable Steroid for Muscle Growth
Primary Component: Methenolone Enanthate
Branded by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (200 mg/mL)

EQ 300

Injectable Steroid for Muscle Growth
Principal Constituent: Boldenone Undecylenate
Producer: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (300 mg/mL)

Sustanon 350

Primary Constituent: Testosterone Blend
Produced by: Dragon Pharmaceutical
Package: 10 mL vial (350 mg/mL)

Winstrol Tabs

Base Ingredient: Stanozolol
Made by: Dragon Pharmaceuticals
Amount: 100 pastilles (50 mg/pill)

Trenbolone 50

Main Constituent: Trenbolone Suspension
Made by: Dragon Pharmaceuticals
Pack: 10 mL vial (50 mg/mL)

Primobolan 100

Prime Chemical Name: Methenolone Enanthate
Branded by: Dragon Pharma
Amount: 10 x 10 mL vial (100 mg/mL)